Passage Bio, Inc. fell 13.7% on Monday, November 9, 2026, on 4,900 shares. No headline about PASG came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Passage Bio, Inc. (PASG:NASDAQ) closed at $4.25 on November 13, 2026, up 5.46% on the day. The stock trades 78.8% below its 52-week high of $20.00 and 29.2% above its 52-week low of $3.29. Over the past year, it lost 52.0%. Passage Bio, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, PASG closed higher on 116 days (46%). Its best day was January 5, 2026 (+37.81%) and its worst was April 20, 2026 (-46.44%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 1 time.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Find more stocks like PASG with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.